Arena Pharmaceuticals Stock News

The company's share price and revenue have soared in 2021, and that's likely only the beginning.

Pfizer Inc.'s presentation of its pending $6.7 billion acquisition of clinical-stage drug company Arena Pharmaceuticals Inc. contained no mention of cannabis.

Written By Gerald Gekara | | Pfizer is joining the medicinal marijuana sector, after banking on a cannabis-based bowel illness treatment firm. Arena Pharmaceuticals, a clinical-stage business, signed an agreement with the biotechnology company to acquire a total ownership stake worth $6.7 billion. According to the agreement, Pfizer will get all shares at $100 per [] The post Pfizer Goes Into Medical Marijuana Production appeared first on Uzalendo News .

Should investors be excited or worried when a stock's 50 -day simple moving average crosses above the 200-day simple moving average?

Among the large drugmakers, stocks of Pfizer (PFE) and Eli Lilly (LLY) rose significantly in 2021 in response to their pipeline progress.

Should investors be excited or worried when a stock's 50 -day simple moving average crosses above the 200-day simple moving average?

Here are three stocks sure to pique the interest of that special someone.

Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha, iTunes, Stitcher and Spotify.

Wells Fargo & Company cut shares of Arena Pharmaceuticals (NASDAQ:ARNA) from an overweight rating to an equal weight rating in a research report report published on Tuesday morning, The Fly reports. Several other brokerages also recently commented on ARNA. Needham & Company LLC reiterated a hold rating on shares of Arena Pharmaceuticals in a report []

Royal Bank of Canada lowered shares of Arena Pharmaceuticals (NASDAQ:ARNA) from an outperform rating to a sector perform rating in a research note issued to investors on Tuesday morning, Price Targets.com reports. They currently have $100.00 price objective on the biopharmaceutical companys stock, up from their prior price objective of $76.00. A number of other []

Below is a recap of the main news related to the cannabis industry and markets for the week of December 13, 2021. Contents Pfizer Getting Into Cannabis Visa vs. Cannabis Retailers Malta's Pa

Shares of Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) saw an uptick in trading volume on Tuesday . 25,018 shares were traded during trading, a decline of 96% from the previous sessions volume of 557,468 shares.The stock last traded at $91.09 and had previously closed at $90.08. Several research firms recently issued reports on ARNA. HC Wainwright reaffirmed []

Arena Pharmaceuticals (NASDAQ:ARNA) was downgraded by equities research analysts at Credit Suisse Group from an outperform rating to a neutral rating in a report issued on Tuesday, The Fly reports. They presently have a $100.00 price target on the biopharmaceutical companys stock, up from their previous price target of $98.00. Credit Suisse Groups target price []

NEW YORK, Dec. 15, 2021 (GLOBE NEWSWIRE) -- Arena Pharmaceuticals, Inc. (NASDAQGS: ARNA)